ReviewOpen veterinary journal2025
Evaluation of the therapeutic effect of a fly maggot antimicrobial peptide in a
Review in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Comprehensive Prevention and Control of Mastitis in Dairy Cows: From Etiology to Prevention.Veterinary sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial peptides (AMPs) have been widely recognized for their robust antimicrobial efficacy and significant activity against diverse pathogens. Aim: Methods: The AMP derived from maggots was isolated, purified, and evaluated for antimicrobial activity. Subsequently, it was applied to treat a murine model of mastitis. A concentration of 25.36 µg/ml AMP was determined as the optimal dose for intramammary administration in mice with Results: The therapeutic efficacy of maggot-derived AMP against Conclusion: This study demonstrated that maggot-derived AMP holds promise as a potential alternative to conventional antibiotics for the treatment of bovine mastitis, offering a viable therapeutic strategy to address antimicrobial resistance and improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.